BeStock  
Stocks › Drug Manufacturers - Specialty & Generic › PCRX

Pacira BioSciences PCRX

US equityMarket cap rank #3237Drug Manufacturers - Specialty & Generic
$25.20 +$0.44 (+1.78%)
Pre-market · Oct 8, 9:10 am ET · After hours $25.20 0.00%
Open$25.05
Prev close$24.76
Day range$24.99 – $26.00
Volume802.7K
Market cap$1.00B
P/E (TTM)72.0
Dividend yield–

PCRX Stock News

Headlines matching Pacira BioSciences or the PCRX ticker, most recent first.

  • Leerink Partners Initiates Pacira BioSciences(PCRX.US) With Hold Rating, Announces Target Price $28Market news · 9 Sep 2026 · Direct mention
  • Truist Financial Maintains Pacira BioSciences(PCRX.US) With Buy RatingMarket news · 21 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $38Market news · 6 Aug 2026 · Direct mention
  • Needham Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Raises Target Price to $33 PositiveMarket news · 5 Aug 2026 · Direct mention
  • Truist Financial Initiates Pacira BioSciences(PCRX.US) With Buy RatingMarket news · 24 Aug 2026 · Direct mention
  • Truist Financial Upgrades Pacira BioSciences(PCRX.US) to Buy Rating, Raises Target Price to $30 PositiveMarket news · 17 Aug 2026 · Direct mention
  • Barclays Maintains Pacira BioSciences(PCRX.US) With Hold Rating, Maintains Target Price $25Market news · 17 Aug 2026 · Direct mention
  • Pacira Pharmaceuticals (PCRX) Receives a Sell From J.P. MorganTipRanks · 10 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Pacira BioSciences(PCRX.US) With Sell Rating, Maintains Target Price $23Market news · 10 Aug 2026 · Direct mention
  • Needham Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $32Market news · 28 Jul 2026 · Direct mention
  • Needham Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Raises Target Price to $32 PositiveMarket news · 1 May 2026 · Direct mention
  • Analysts' Top Healthcare Picks: Pacira Pharmaceuticals (PCRX), Cadrenal Therapeutics, Inc. (CVKD)TipRanks · 1 May 2026 · Direct mention
  • H.C. Wainwright Reaffirms Their Buy Rating on Pacira Pharmaceuticals (PCRX)TipRanks · 20 Apr 2026 · Direct mention
  • Needham Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $30Market news · 16 Apr 2026 · Direct mention
  • Barclays Maintains Pacira BioSciences(PCRX.US) With Hold Rating, Cuts Target Price to $25 NegativeMarket news · 26 Mar 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on PCRX.

Leave a comment

Scroll to Top